Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell‐derived extracellular vesicles

Abstract

Mesenchymal stem cell (MSC)‐derived extracellular vesicles (EVs) have emerged as potential therapeutic agents for numerous applications. EVs offer potential advantages over cell‐based therapies with regard to safety, stability and clearance profiles, however production and potency limitations must be addressed to enable eventual translation of EV‐based approaches. Thus, we sought to examine the role of specific cell culture parameters on MSC EV production and bioactivity toward informing rational design parameters for scalable EV biomanufacturing. We report significantly reduced MSC EV vascularization bioactivity, as measured by an endothelial cell gap closure assay, with increasing passage in culture by trypsinization, especially beyond passage 4. We further show that increased frequency of EV collection yielded higher numbers of EVs from the same initial number of MSCs over a 24 hr period. Finally, we demonstrate that decreased cell seeding density in culture flasks resulted in increased production of EVs per cell in MSCs and other cell types. Overall, these studies highlight the need for careful consideration of the parameters of cell passage number and cell seeding density in the production of therapeutic EVs at laboratory scale and for rational design of large‐scale EV biomanufacturing schemes.

Cited by papers we hold 13

• Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment · 2025
  Not checked
• Immune response following traumatic spinal cord injury: Pathophysiology and therapies · 2023
  No notice
• Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review · 2022
  No notice
• Engineering extracellular vesicles by three‐dimensional dynamic culture of human mesenchymal stem cells · 2022
  No notice
• Biological Features of Extracellular Vesicles and Challenges · 2022
  No notice
• Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities · 2021
  No notice
• Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration · 2021
  No notice
• Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation · 2021
  No notice
• Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation · 2020
  No notice
• miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury · 2020
  No notice
• Hypoxia Conditioned Mesenchymal Stem Cell-Derived Extracellular Vesicles Induce Increased Vascular Tube Formation in vitro · 2019
  No notice
• Challenges in Exosome Isolation and Analysis in Health and Disease · 2019
  No notice
• Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.